RGNX R&D Expense Growth
Regenxbio Inc · R&D Expense Growth
RGNX R&D Expense Growth
Latest reported9.48%period ending
RGNX FY R&D Growth (YoY) (0.00% → 9.48%)
Latest values, visible window
High-resolution chart · PNG
RGNX r&d expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expense Growth |
|---|---|
| 9.4844% | |
| -10.2228% | |
| -4.2016% | |
| 33.6293% | |
| 9.1062% | |
| 33.9083% | |
| 48.0631% | |
| 46.5696% | |
| 25.8168% | |
| 163.2213% | |
| 248.2967% | |
| -1.7818% | |
| 0% |